Case number 1:20-cv-01153
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited, et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 22, 2022 | 47 | Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding rescheduled Markman hearing. (Attachments: # 1 Enclosure)(Phillips, John) (Entered: 09/22/2022) (Enclosure) (30) |
| Sep 22, 2022 | 47 | Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding rescheduled Markman hearing. (Attachments: # 1 Enclosure)(Phillips, John) (Entered: 09/22/2022) (Main Document) (2) |
| Sep 14, 2022 | 46 | NOTICE requesting Clerk to remove Michael K. Nutter as co-counsel. Reason for request: No longer affiliated with the case. (Bilson, David) (Entered: 09/14/2022) (1) |
| Jul 25, 2022 | 45 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jason Z. Pesick as co-counsel. Reason for request: No Longer with Winston & Strawn LLP. (Bilson, David) |
| Jun 14, 2022 | 44 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding joint letter regarding discovery dispute. (Phillips, John) |
| Apr 18, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Civil Action No. 20-1153-CFC and Civil Action No. 21-530-CFC are consolidated for all purposes. All future filings shall be made in Lead Case No. 20-1153-CFC only. Ordered by Judge Colm F. Connolly on 4/18/2022. (nmf) |
| Apr 8, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER- Whereas, I find this case is an exceptional one for which ADR is appropriate, I will continue to mediate this matter in accordance with the original referral made in the Oral Order of 2/16/2021. Ordered by Judge Sherry R. Fallon on 4/8/2022. (lih) |
| Mar 10, 2022 | 43 | SO ORDERED (4) Docket Text: SO ORDERED, re [42] STIPULATION and Order to Amend Scheduling Order, Set/Reset Scheduling Order Deadlines: ( Amended Pleadings due by 12/15/2022., Joinder of Parties due by 12/15/2022., A Markman Hearing is set for 12/9/2022 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly.) Signed by Judge Colm F. Connolly on 3/9/2022. (nmf) |
| Mar 8, 2022 | 42 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order to Amend Scheduling Order by Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc.. (Phillips, John) |
| Mar 8, 2022 | 41 | Certification of Jason Z. Pesick (1) |
| Mar 8, 2022 | 41 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jason Z. Pesick - filed by Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc.. (Attachments: # (1) Certification of Jason Z. Pesick)(Bilson, David) |
| Mar 8, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jason Z. Pesick for Sun Pharmaceutical Industries Limited, and Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Mar 8, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [41] MOTION for Pro Hac Vice Appearance of Attorney Jason Z. Pesick, filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited. Ordered by Judge Colm F. Connolly on 3/8/2022. (kmd) |
| Jan 28, 2022 | 40 | SO ORDERED (3) Docket Text: SO ORDERED, re [39] Stipulation and [Proposed] Order to Amend Scheduling Order, filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited. Re-Setting Scheduling Order Deadlines: Claim Construction Opening Brief due by 8/11/2022. Signed by Judge Colm F. Connolly on 1/28/2022. (kmd) |
| Jan 27, 2022 | 39 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Amend Scheduling Order by Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc.. (Bilson, David) |
| Dec 20, 2021 | 38 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Preliminary Infringement Contentions Against Sun for Its ANDA Product Associated with ANDA No. 215529 for U.S. Patents No. 7,579,449, 9,949,998, 10,258,637 & 10,596,120; and (2) Plaintiffs' Preliminary Infringement Contentions Against Sun for Its ANDA Product Associated with ANDA No. 214843 for U.S. Patents No. 7,579,449, 8,551,957, 9,155,705, 9,415,016, 9,949,998, 10,022,379, 10,258,637, 10,406,172 & 10,596,120 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Nov 15, 2021 | 37 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Identification of Asserted Claims filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Oct 14, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [36] STIPULATION TO EXTEND TIME of (i) Plaintiffs' Disclosure of Asserted Claims, and (ii) Plaintiffs' Initial Infringement Contentions to November 15, 2021 and December 17, 2021, respectively filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 10/14/2021. (kmd) |
| Oct 13, 2021 | 36 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME of (i) Plaintiffs' Disclosure of Asserted Claims, and (ii) Plaintiffs' Initial Infringement Contentions to November 15, 2021 and December 17, 2021, respectively - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jul 9, 2021 | 35 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Identification of Asserted Patents filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 14, 2021 | 34 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Corrected Rule 26(a) Initial Disclosures and (2) Plaintiffs' Corrected Disclosures Under Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 14, 2021 | 33 | Protective Order (30) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 6/14/2021. (fms) |
| Jun 11, 2021 | 32 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Rule 26(a) Initial Disclosures and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jun 11, 2021 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharmaceutical Industries Limited's and Sun Pharmaceutical Industries, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and Defendants Sun Pharmaceutical Industries Limited's and Sun Pharmaceutical Industries, Inc.'s Disclosures Pursuant to Rule 26(a)(1) filed by Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc..(Phillips, John) |
| Jun 11, 2021 | 30 | SO ORDERED (5) Docket Text: SO ORDERED, re (18 in 1:21-cv-00356-CFC, 28 in 1:20-cv-01153-CFC, 27 in 1:20-cv-01585-CFC) STIPULATION Regarding Consolidation. These cases are consolidated for all purposes and all future filings shall be made in Lead Case No. 20-1153-CFC. Signed by Judge Colm F. Connolly on 6/10/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC, 1:21-cv-00356-CFC(nmf) |
| Jun 10, 2021 | 29 | Proposed Order (30) Docket Text: PROPOSED ORDER Stipulated Protective Order by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jun 8, 2021 | 28 | Stipulation (5) Docket Text: STIPULATION Regarding Consolidation by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jun 2, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (26 in 1:20-cv-01585-CFC, 27 in 1:20-cv-01153-CFC) Joint STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to June 10, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 6/2/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(fms) |
| Jun 1, 2021 | 27 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to June 10, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| May 6, 2021 | 26 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| May 6, 2021 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharmaceutical Industries Limited's and Sun Pharmaceutical Industries, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited.(Bilson, David) |
| Apr 22, 2021 | 24 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a) Initial Disclosures filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Apr 22, 2021 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharmaceutical Industries Limited's and Sun Pharmaceuticals Industries, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) filed by Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited.(Bilson, David) |
| Mar 4, 2021 | 22 | SO ORDERED (4) Docket Text: SO ORDERED, re [21] Stipulation filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited, Ohm Laboratories, Inc. Party Ohm Laboratories, Inc. terminated. Signed by Judge Colm F. Connolly on 3/4/2021. (fms) |
| Mar 3, 2021 | 21 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Dismissing Defendant Ohm Laboratories, Inc. and Amending Caption by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc.. (Bilson, David) |
| Feb 16, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Feb 11, 2021 | 20 | Scheduling Order (20) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 10/28/2022. Expert Discovery due by 6/30/2023. Joint Claim Construction Brief due by 7/21/2022. A Markman Hearing is set for 9/13/2022 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 7/26/2023. A Final Pretrial Conference is set for 8/16/2023 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 9/11/2023 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 2/11/2021. (nmf) |
| Feb 5, 2021 | 19 | Proposed Order (20) Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Feb 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (17 in 1:20-cv-01585-CFC, 18 in 1:20-cv-01153-CFC) STIPULATION TO EXTEND TIME for the Parties to submit a proposed Scheduling Order to February 5, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 2/4/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(fms) |
| Feb 3, 2021 | 18 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to submit a proposed Scheduling Order to February 5, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Jan 28, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (17 in 1:20-cv-01153-CFC, 16 in 1:20-cv-01585-CFC) STIPULATION TO EXTEND TIME for the Parties to submit a proposed Scheduling Order to February 3, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 1/28/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(fms) |
| Jan 27, 2021 | 17 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to submit a proposed Scheduling Order to February 3, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jan 26, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bryce A. Cooper for Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC.(kmd) |
| Jan 26, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles B. Klein for Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01585-CFC, 1:20-cv-01153-CFC. (kmd) |
| Jan 25, 2021 | 16 | Cooper Pro Hac Certification (1) |
| Jan 25, 2021 | 16 | Klein Pro Hac Certification (1) |
| Jan 25, 2021 | 16 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein and Bryce A. Cooper - filed by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc.. (Attachments: # (1) Klein Pro Hac Certification, # (2) Cooper Pro Hac Certification)(Bilson, David) |
| Jan 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein and Bryce A. Cooper filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited,, Ohm Laboratories, Inc. Signed by Judge Colm F. Connolly on 1/25/2021. (fms) |
| Jan 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-01153-CFC, 14 in 1:20-cv-01585-CFC) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 27, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 1/21/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(fms) |
| Jan 20, 2021 | 15 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 27, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Dec 23, 2020 | 14 | Disclosure Statement (2) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Limited for Ohm Laboratories, Inc., Sun Pharmaceutical Industries, Inc. filed by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc.. (Phillips, John) |
| Dec 17, 2020 | 13 | Order (2) Docket Text: ORDER, on or before January 20, 2021, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/20/2021.) Signed by Judge Colm F. Connolly on 12/17/2020. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(nmf) |
| Oct 30, 2020 | 12 | Answer to Counterclaim (30) Docket Text: ANSWER to [10] Answer to Complaint,, Counterclaim, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Oct 9, 2020 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Limited for Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc. filed by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc.. (Phillips, John) |
| Oct 9, 2020 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and, COUNTERCLAIM For Declaratory Judgment of Defendants against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc..(Phillips, John) |
| Sep 18, 2020 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries Limited, served on 9/18/2020, answer due 10/9/2020. (Egan, Brian) |
| Sep 18, 2020 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries, Inc. served on 9/18/2020, answer due 10/9/2020. (Egan, Brian) |
| Sep 18, 2020 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Ohm Laboratories, Inc. served on 9/18/2020, answer due 10/9/2020. (Egan, Brian) |
| Sep 2, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Aug 31, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (sam) |
| Aug 31, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: [1] Complaint replaced per counsel's request to reflect corrected signature block. (kmd) |
| Aug 28, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn Ag & Co. Kg for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (sam) |
| Aug 28, 2020 | 4 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 20, 2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/20/2023. (sam) |
| Aug 28, 2020 | 3 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) SEE ATTACHED. (sam) |
| Aug 28, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Aug 28, 2020 | 1 | Complaint* (1) |
| Aug 28, 2020 | 1 | Civil Cover Sheet (1) |
| Aug 28, 2020 | 1 | Exhibit 1-8 (295) |
| Aug 28, 2020 | 1 | Main Document (28) Docket Text: COMPLAINT filed against Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3162805.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit 1-8, # (2) Civil Cover Sheet)(sam) (Main Document 1 replaced on 8/31/2020) (kmd). |
